RAPAMUNE 2 mg (Rapamune 2 mg)
Generic Name: sirolimus
This pill with imprint "RAPAMUNE 2 mg" is Beige, Three-sided and has been identified as Rapamune 2 mg. It is manufactured by Wyeth-Ayerst Laboratories.
Rapamune is used in the treatment of lymphangioleiomyomatosis; organ transplant, rejection prophylaxis and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Rapamune 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- sirolimus
- Imprint:
- RAPAMUNE 2 mg
- Strength:
- 2 mg
- Color:
- Beige
- Shape:
- Three-sided
- Availability:
- Prescription only
- Drug Class:
- MTOR inhibitors
Selective immunosuppressants - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Wyeth-Ayerst Laboratories
More about Rapamune (sirolimus)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Generic Availability
- Drug class: mTOR inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
